SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+10.1%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$558M
AUM Growth
+$558M
(+14%)
Cap. Flow
+$28M
Cap. Flow
% of AUM
5.02%
Top 10 Holdings %
Top 10 Hldgs %
37.48%
Holding
150
New
25
Increased
36
Reduced
26
Closed
23
Top Buys
| 1 |
CEL
Cellcom Israel, Ltd.
CEL
|
$14.3M |
| 2 |
AGN
Allergan plc
AGN
|
$12.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$7.04M |
| 4 |
Merck
MRK
|
$6.72M |
| 5 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$6.38M |
Top Sells
| 1 |
Novartis
NVS
|
$16M |
| 2 |
Bristol-Myers Squibb
BMY
|
$13.8M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.2M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$3.99M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$3.63M |
Sector Composition
| 1 | Healthcare | 79.06% |
| 2 | Technology | 7.13% |
| 3 | Communication Services | 3.32% |
| 4 | Industrials | 1.33% |
| 5 | Financials | 1.29% |
